Serum level of estrogen in Iranian patients with oral lichen planus

[1] Agha-Hosseini F, Moosavi MS, Sadrzadeh Afshar MS, Sheykhbahaei N. Assessment of the relationship between stress and oral lichen planus: a review of literature. J Islam Dent Assoc Iran. 2016; 28:78–85. Agha-HosseiniF MoosaviMS Sadrzadeh AfsharMS SheykhbahaeiN Assessment of the relationship between stress and oral lichen planus: a review of literature J Islam Dent Assoc Iran 2016 28 78 85 10.30699/jidai.29.2.78 Search in Google Scholar

[2] Agha-Hosseini F, Sheykhbahaei N, SadrZadeh-Afshar M-S. Evaluation of potential risk factors that contribute to malignant transformation of oral lichen planus: a literature review. J Contemp Dent Pract. 2016; 17:692–701. Agha-HosseiniF SheykhbahaeiN SadrZadeh-AfsharM-S Evaluation of potential risk factors that contribute to malignant transformation of oral lichen planus: a literature review J Contemp Dent Pract 2016 17 692 701 10.5005/jp-journals-10024-1914 Search in Google Scholar

[3] Boorghani M, Gholizadeh N, Zenouz AT, Vatankhah M, Mehdipour M. Oral lichen planus: clinical features, etiology, treatment and management; a review of literature. J Dent Res Dent Clin Dent Prospect. 2010; 4:3–9. doi: 10.5681/joddd.2010.002 BoorghaniM GholizadehN ZenouzAT VatankhahM MehdipourM Oral lichen planus: clinical features, etiology, treatment and management; a review of literature J Dent Res Dent Clin Dent Prospect 2010 4 3 9 10.5681/joddd.2010.002 Open DOISearch in Google Scholar

[4] Katne T, Muppirala AVS, Devaraju RR, Gantala R. A potent regimen for oral lichen planus: a review. Ann Essence Dentist. 2017; 9:7c–11c. doi: 10.5368/aedj.2017.9.2.3.2 KatneT MuppiralaAVS DevarajuRR GantalaR A potent regimen for oral lichen planus: a review Ann Essence Dentist. 2017 9 7c 11c 10.5368/aedj.2017.9.2.3.2 Open DOISearch in Google Scholar

[5] Yarnell E, Abascal K. Herbal treatment for lichen planus. Altern Complement Ther. 2010; 16:217–22. YarnellE AbascalK Herbal treatment for lichen planus Altern Complement Ther 2010 16 217 22 10.1089/act.2010.16408 Search in Google Scholar

[6] Straub RH. The complex role of estrogens in inflammation. Endocr Rev. 2007; 28:521–74. StraubRH The complex role of estrogens in inflammation Endocr Rev 2007 28 521 74 10.1210/er.2007-0001 Search in Google Scholar

[7] Ahmed SA. The immune system as a potential target for environmental estrogens (endocrine disrupters): a new emerging field. Toxicology. 2000; 150:191–206. AhmedSA The immune system as a potential target for environmental estrogens (endocrine disrupters): a new emerging field Toxicology 2000 150 191 206 10.1016/S0300-483X(00)00259-6 Search in Google Scholar

[8] von Elm E, Altman DG, Egger M, Pocock SJ, Gøtzsche PC, Vandenbroucke JP; STROBE initiative. The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. Int J Surg. 2014; 12:1495–9. von ElmE AltmanDG EggerM PocockSJ GøtzschePC VandenbrouckeJP STROBE initiative The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies Int J Surg 2014 12 1495 9 10.1097/EDE.0b013e318157765418049194 Search in Google Scholar

Seriolo B, Cutolo M, Garnero A, Accardo S. Relationships between serum 17 β-oestradiol and anticardiolipin antibody concentrations in female patients with rheumatoid arthritis. Rheumatology (Oxford). 1999; 38:1159–61. SerioloB CutoloM GarneroA AccardoS Relationships between serum 17 β-oestradiol and anticardiolipin antibody concentrations in female patients with rheumatoid arthritis Rheumatology (Oxford) 1999 38 1159 61 10.1093/rheumatology/38.11.115910556275 Search in Google Scholar

[10] Tengstrand B, Carlström K, Felländer-Tsai L, Hafström I. Abnormal levels of serum dehydroepiandrosterone, estrone, and estradiol in men with rheumatoid arthritis: high correlation between serum estradiol and current degree of inflammation. J Rheumatol. 2003; 30:2338–43. TengstrandB CarlströmK Felländer-TsaiL HafströmI Abnormal levels of serum dehydroepiandrosterone, estrone, and estradiol in men with rheumatoid arthritis: high correlation between serum estradiol and current degree of inflammation J Rheumatol 2003 30 2338 43 Search in Google Scholar

[11] Calabrese EJ. Estrogen and related compounds: biphasic dose responses. Crit Rev Toxicol. 2001; 31:503–15. CalabreseEJ Estrogen and related compounds: biphasic dose responses Crit Rev Toxicol 2001 31 503 15 10.1080/2001409111178511504177 Search in Google Scholar

[12] Kanda N, Tamaki K. Estrogen enhances immunoglobulin production by human PBMCs. J Allergy Clin Immunol. 1999; 103:282–8. KandaN TamakiK Estrogen enhances immunoglobulin production by human PBMCs J Allergy Clin Immunol 1999 103 282 8 10.1016/S0091-6749(99)70503-8 Search in Google Scholar

[13] Verheul H, Schot L, Schuurs H. Therapeutic effects of nandrolone decanoate, tibolone, lynestrenol and ethylestrenol on Sjögren's syndrome-like disorder in NZB/W mice. Clin Exp Immunol. 1986; 64:243–8. VerheulH SchotL SchuursH Therapeutic effects of nandrolone decanoate, tibolone, lynestrenol and ethylestrenol on Sjögren's syndrome-like disorder in NZB/W mice Clin Exp Immunol 1986 64 243 8 Search in Google Scholar

[14] MacKenzie-Graham AJ, Rinek GA, Avedisian A, Morales LB, Umeda E, Boulat B, et al. Estrogen treatment prevents gray matter atrophy in experimental autoimmune encephalomyelitis. J Neurosci Res. 2012; 90:1310–23. MacKenzie-GrahamAJ RinekGA AvedisianA MoralesLB UmedaE BoulatB Estrogen treatment prevents gray matter atrophy in experimental autoimmune encephalomyelitis J Neurosci Res 2012 90 1310 23 10.1002/jnr.23019335061422411609 Search in Google Scholar

[15] Vandenbroucke JP, Witteman JC, Valkenburg HA, Boersma JW, Cats A, Festen JJ, et al. Noncontraceptive hormones and rheumatoid arthritis in perimenopausal and postmenopausal women. JAMA. 1986; 255:1299–303. VandenbrouckeJP WittemanJC ValkenburgHA BoersmaJW CatsA FestenJJ Noncontraceptive hormones and rheumatoid arthritis in perimenopausal and postmenopausal women JAMA 1986 255 1299 303 10.1001/jama.1986.03370100093024 Search in Google Scholar

[16] Gholizadeh N, Poorfar HK, Taghavi Zenouz A, Vatandoost M, Mehdipour M. Comparison of serum autoantibodies to desmogleins I, III in patients with oral lichen planus and healthy controls. Iran J Pathol. 2015; 10:136–40. GholizadehN PoorfarHK Taghavi ZenouzA VatandoostM MehdipourM Comparison of serum autoantibodies to desmogleins I, III in patients with oral lichen planus and healthy controls Iran J Pathol 2015 10 136 40 Search in Google Scholar

[17] Ansar Ahmed S, Hissong BD, Verthelyi D, Donner K, Becker K, Karpuzoglu-Sahin E. Gender and risk of autoimmune diseases: possible role of estrogenic compounds. Environ Health Perspect. 1999; 107(Suppl 5):681–6. Ansar AhmedS HissongBD VerthelyiD DonnerK BeckerK Karpuzoglu-SahinE Gender and risk of autoimmune diseases: possible role of estrogenic compounds Environ Health Perspect. 1999 107 Suppl 5 681 6 10.1289/ehp.99107s5681156625010502531 Search in Google Scholar

[18] Losordo DW, Isner JM. Estrogen and angiogenesis: a review. Arterioscler Thromb Vasc Biol. 2001; 21:6–12. LosordoDW IsnerJM Estrogen and angiogenesis: a review Arterioscler Thromb Vasc Biol 2001 21 6 12 10.1161/01.ATV.21.1.6 Search in Google Scholar

[19] Cutolo M, Capellino S, Sulli A, Serioli B, Secchi ME, Villaggio B, Straub RH. Estrogens and autoimmune diseases. Ann N Y Acad Sci. 2006; 1089:538–47. CutoloM CapellinoS SulliA SerioliB SecchiME VillaggioB StraubRH Estrogens and autoimmune diseases Ann N Y Acad Sci 2006 1089 538 47 10.1196/annals.1386.04317261796 Search in Google Scholar

[20] Rider V, Jones SR, Evans M, Abdou NI. Molecular mechanisms involved in the estrogen-dependent regulation of calcineurin in systemic lupus erythematosus T cells. Clin Immunol. 2000; 95:124–34. RiderV JonesSR EvansM AbdouNI Molecular mechanisms involved in the estrogen-dependent regulation of calcineurin in systemic lupus erythematosus T cells Clin Immunol 2000 95 124 34 10.1006/clim.2000.484410779406 Search in Google Scholar

[21] Vohra S, Singal A, Sharma SB. Clinical and serological efficacy of topical calcineurin inhibitors in oral lichen planus: a prospective randomized controlled trial. Int J Dermatol. 2016; 55:101–5. VohraS SingalA SharmaSB Clinical and serological efficacy of topical calcineurin inhibitors in oral lichen planus: a prospective randomized controlled trial Int J Dermatol 2016 55 101 5 10.1111/ijd.1288726147635 Search in Google Scholar